SUMMARY Cardiac contractility and coronary flow were compared in conscious rats with established deoxycorticosterone acetate-salt hypertension and in those with sham treatment. The hypertensive rats showed a 32% increase in left ventricular/body weight ratio at 9 weeks of treatment and 42% at 18 weeks of treatment. Resting peak rate of change of pressure (dp/dt) was unchanged at 9 weeks and increased at 18 weeks in hypertensive rats, while isoproterenol-stimulated maximal, propranololinduced minimal, and Ca
2+-stimulated maximal peak dp/dt were greater at 18 weeks. These data indicate the preservation of contractile function. At 18 weeks, the /3-adrenergic receptor-mediated contractile reserve, estimated from isoproterenol-stimulated maximal and resting peak dp/dt, was reduced but the propranolol-induced decrease in peak dp/dt was increased in hypertensive rats compared with sham-treated rats. Thus, at this stage, a greater portion of the total contractile capacity appeared to be mobilized with prolongation of hypertension and progression of left ventricular hypertrophy. No differences were observed in left ventricular and right ventricular coronary flow (microspheres) and left ventricular inner/outer flow ratio at rest and with dipyridamole-induced maximal coronary dilatation, at 9 and 18 weeks. There were no alterations in left or right ventricular coronary flow reserves, as estimated from resting and dipyridamole-induced values. The minimal coronary vascular resistance (normalized for gram of tissue) of both the left and right ventricles was increased at either stage, which suggests the occurrence of structural coronary vascular changes. Thus, basal coronary flow and a coronary flow reserve were uncompromised despite evidence of structural coronary vascular alterations in these hypertensive rats. (Hypertension 7: 569-577, 1985) KEY WORDS • left ventricular hypertrophy • minimal coronary vascular resistance peak rate of change of pressure (dp/dt) • radioactive microspheres • isoproterenol propranolol • dipyridamole S YSTEMIC hypertension often leads to alterations in cardiac performance associated with an increase in cardiac mass 1 "" and coronary circulation. '-l2 " 19 There is still considerable controversy regarding cardiac performance in the presence of hypertension, 1 ""-l3 most of which stems from the wide spectrum of cardiac function caused by variations in the duration, severity, and type of hypertension.Little is known of cardiac function and coronary hemodynamics in deoxycorticosterone acetate (DOCA)-salt hypertension. The literature seems to consist of reports on the unaltered mechanical properties of isolated papillary muscles 13 and the increased intercapillary distance of superficial epicardial muscles. 19 In view of this and earlier data on some features of hemodynamic, 20 neurohumoral, 2 '-" and myocardial and coronary vascular histopathological 12 changes in this form of hypertension, we wanted to assess cardiac function and coronary hemodynamics in DOCA-salt hypertensive rats. Since we ...